Dyne Therapeutics Ownership 2024 | Who Owns Dyne Therapeutics Now?
Institutional Ownership
136.95%
Insider Ownership
0.39%
Retail Ownership
-37.35%
Institutional Holders
197.00
Dyne Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 9.90% | 29.80% | 8,020,136 | - | - | 283,030,599 | Jun 30, 2024 |
| FCPM III SERVICES B.V. | 9.68% | 40.83% | 7,845,364 | - | - | 276,862,896 | Jun 30, 2024 |
| BLACKROCK INC. | 9.11% | 0.01% | 7,386,988 | 1,996,946 | 37.05% | 260,686,805 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 7.88% | 3.49% | 6,387,138 | 3,295,551 | 106.60% | 225,402,100 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 7.46% | 2.82% | 6,049,204 | 1,094,425 | 22.09% | 213,476,409 | Jun 30, 2024 |
| FMR LLC | 6.56% | 0.01% | 5,318,963 | 2,100,570 | 65.27% | 187,706,204 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.82% | 0.00% | 4,718,054 | 1,277,784 | 37.14% | 166,500,126 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 5.71% | 0.09% | 4,623,824 | 1,948,584 | 72.84% | 163,242,973 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 4.94% | 4.21% | 4,000,000 | -555,383 | -12.19% | 141,160,000 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.11% | 0.22% | 3,328,000 | 1,003,000 | 43.14% | 117,445,120 | Jun 30, 2024 |
| STATE STREET CORP | 3.95% | 0.00% | 3,200,969 | -992,584 | -23.67% | 112,962,196,000 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 3.27% | 9.75% | 2,650,150 | - | - | 93,523,794 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.92% | 0.01% | 2,366,069 | 1,233,977 | 109.00% | 83,500,000 | Jun 30, 2024 |
| VR ADVISER, LLC | 2.68% | 4.89% | 2,173,913 | - | - | 76,717,390 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.59% | 0.01% | 2,095,749 | 434,661 | 26.17% | 73,958,982 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 2.56% | 0.31% | 2,076,352 | 2,076,352 | 100.00% | 73,274,462 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.19% | 0.01% | 1,774,653 | 467,049 | 35.72% | 62,638,544 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 2.12% | 0.02% | 1,714,496 | -68,775 | -3.86% | 60,504,578 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 2.02% | 5.33% | 1,635,136 | - | - | 57,703,949 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 2.01% | 2.98% | 1,625,703 | -310,947 | -16.06% | 57,371,059 | Jun 30, 2024 |
Dyne Therapeutics's largest institutional shareholder is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, holding 9.90% of the company's total share outstanding, currently valued at $283.03M. The top 10 institutional shareholders own together 71.17% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FCPM III SERVICES B.V. | 9.68% | 40.83% | 7,845,364 | - | - | 276,862,896 | Jun 30, 2024 |
| MPM ASSET MANAGEMENT LLC | 1.93% | 30.26% | 1,561,496 | -1,889,807 | -54.76% | 55,105,194 | Jun 30, 2024 |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 9.90% | 29.80% | 8,020,136 | - | - | 283,030,599 | Jun 30, 2024 |
| VIDA VENTURES ADVISORS, LLC | 0.50% | 15.73% | 407,499 | - | - | 14,380,640 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 3.27% | 9.75% | 2,650,150 | - | - | 93,523,794 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 1.46% | 6.55% | 1,180,798 | -62,147 | -5.00% | 41,670,361 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.26% | 6.32% | 212,500 | 28,000 | 15.18% | 7,499,125 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 2.02% | 5.33% | 1,635,136 | - | - | 57,703,949 | Jun 30, 2024 |
| VR ADVISER, LLC | 2.68% | 4.89% | 2,173,913 | - | - | 76,717,390 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 4.94% | 4.21% | 4,000,000 | -555,383 | -12.19% | 141,160,000 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 7.88% | 3.49% | 6,387,138 | 3,295,551 | 106.60% | 225,402,100 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 2.01% | 2.98% | 1,625,703 | -310,947 | -16.06% | 57,371,059 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 7.46% | 2.82% | 6,049,204 | 1,094,425 | 22.09% | 213,476,409 | Jun 30, 2024 |
| RATAN CAPITAL MANAGEMENT LP | 0.28% | 2.47% | 230,900 | 201,900 | 696.21% | 8,148,461 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.87% | 1.36% | 1,516,960 | -1,000 | -0.07% | 53,533,518 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 0.47% | 1.18% | 382,433 | 276,485 | 260.96% | 13,496,061 | Jun 30, 2024 |
| EAM GLOBAL INVESTORS LLC | 0.16% | 1.01% | 127,247 | 127,247 | 100.00% | 4,490,547 | Jun 30, 2024 |
| LISANTI CAPITAL GROWTH, LLC | 0.13% | 0.90% | 106,140 | 19,530 | 22.55% | 3,745,681 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.15% | 0.82% | 119,488 | - | - | 4,216,732 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.33% | 0.76% | 265,000 | -1,465,000 | -84.68% | 9,351,850 | Jun 30, 2024 |
The largest Dyne Therapeutics shareholder by % of total assets is FCPM III SERVICES B.V.. The company owns 7.85M shares of Dyne Therapeutics (DYN), representing 40.83% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 7.88% | 3.49% | 6,387,138 | 3,295,551 | 106.60% | 225,402,100 | Jun 30, 2024 |
| FMR LLC | 6.56% | 0.01% | 5,318,963 | 2,100,570 | 65.27% | 187,706,204 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 2.56% | 0.31% | 2,076,352 | 2,076,352 | 100.00% | 73,274,462 | Jun 30, 2024 |
| BLACKROCK INC. | 9.11% | 0.01% | 7,386,988 | 1,996,946 | 37.05% | 260,686,805 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 5.71% | 0.09% | 4,623,824 | 1,948,584 | 72.84% | 163,242,973 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.82% | 0.00% | 4,718,054 | 1,277,784 | 37.14% | 166,500,126 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.92% | 0.01% | 2,366,069 | 1,233,977 | 109.00% | 83,500,000 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 7.46% | 2.82% | 6,049,204 | 1,094,425 | 22.09% | 213,476,409 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.11% | 0.22% | 3,328,000 | 1,003,000 | 43.14% | 117,445,120 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.13% | 0.39% | 919,416 | 537,000 | 140.42% | 32,446,191 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 1.52% | 0.42% | 1,233,908 | 535,981 | 76.80% | 43,544,613 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.60% | 0.29% | 485,000 | 485,000 | 100.00% | 17,115,650 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.59% | 0.14% | 477,000 | 477,000 | 100.00% | 16,833,330 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.19% | 0.01% | 1,774,653 | 467,049 | 35.72% | 62,638,544 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 0.56% | 0.05% | 452,213 | 452,213 | 100.00% | 15,959,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.59% | 0.01% | 2,095,749 | 434,661 | 26.17% | 73,958,982 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 0.83% | 0.30% | 672,096 | 387,096 | 135.82% | 23,718,268 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.36% | 0.01% | 294,748 | 294,748 | 100.00% | 10,401,657 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 0.47% | 1.18% | 382,433 | 276,485 | 260.96% | 13,496,061 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 0.28% | 0.59% | 225,000 | 225,000 | 100.00% | 7,940,250 | Jun 30, 2024 |
As of Jun 30 2024, Dyne Therapeutics's largest institutional buyer is RTW INVESTMENTS, LP. The company purchased 3.30M stocks of DYN, valued at $225.40M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1.93% | 30.26% | 1,561,496 | -1,889,807 | -54.76% | 55,105,194 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.33% | 0.76% | 265,000 | -1,465,000 | -84.68% | 9,351,850 | Jun 30, 2024 |
| STATE STREET CORP | 3.95% | 0.00% | 3,200,969 | -992,584 | -23.67% | 112,962,196,000 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 4.94% | 4.21% | 4,000,000 | -555,383 | -12.19% | 141,160,000 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -435,256 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.69% | 0.00% | 559,052 | -403,112 | -41.90% | 19,728,946 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.44% | 0.03% | 357,518 | -328,916 | -47.92% | 12,616,810 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 2.01% | 2.98% | 1,625,703 | -310,947 | -16.06% | 57,371,059 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.39% | 0.02% | 312,752 | -298,541 | -48.84% | 11,037,018 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.18% | 0.02% | 145,378 | -199,013 | -57.79% | 5,130,390 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.21% | 0.00% | 171,185 | -155,444 | -47.59% | 6,041,462 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.14% | 0.03% | 115,195 | -154,562 | -57.30% | 4,065,231 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.66% | 0.11% | 533,273 | -142,351 | -21.07% | 18,818,326 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -100,656 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -99,822 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.10% | 0.39% | 85,000 | -85,000 | -50.00% | 2,999,650 | Jun 30, 2024 |
| WASATCH ADVISORS LP | 0.41% | 0.06% | 335,615 | -82,179 | -19.67% | 11,843,853 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 2.12% | 0.02% | 1,714,496 | -68,775 | -3.86% | 60,504,578 | Jun 30, 2024 |
| AXA S.A. | 0.26% | 0.02% | 210,149 | -68,417 | -24.56% | 7,416,158 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.12% | 0.00% | 100,750 | -68,213 | -40.37% | 3,555,468 | Jun 30, 2024 |
As of Jun 30 2024, Dyne Therapeutics's biggest institutional seller is MPM ASSET MANAGEMENT LLC. The company sold -1.89M shares of DYN, valued at $55.11M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| HOLOCENE ADVISORS, LP | 2.56% | 0.31% | 2,076,352 | 2,076,352 | 100.00% | 73,274,462 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.60% | 0.29% | 485,000 | 485,000 | 100.00% | 17,115,650 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.59% | 0.14% | 477,000 | 477,000 | 100.00% | 16,833,330 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 0.56% | 0.05% | 452,213 | 452,213 | 100.00% | 15,959,000 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.36% | 0.01% | 294,748 | 294,748 | 100.00% | 10,401,657 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 0.28% | 0.59% | 225,000 | 225,000 | 100.00% | 7,940,250 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.25% | 0.63% | 201,000 | 201,000 | 100.00% | 7,093,290 | Jun 30, 2024 |
| EAM GLOBAL INVESTORS LLC | 0.16% | 1.01% | 127,247 | 127,247 | 100.00% | 4,490,547 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.16% | 0.01% | 126,000 | 126,000 | 100.00% | 4,446,540 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 0.14% | 0.05% | 115,751 | 115,751 | 100.00% | 4,084,853 | Jun 30, 2024 |
| NORGES BANK | 0.13% | 0.00% | 107,089 | 107,089 | 100.00% | 3,779,171 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.12% | 0.34% | 100,000 | 100,000 | 100.00% | 3,529,000 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.12% | 0.41% | 100,000 | 100,000 | 100.00% | 3,529,000 | Jun 30, 2024 |
| TREK FINANCIAL, LLC | 0.12% | 0.28% | 99,959 | 99,959 | 100.00% | 3,527,553 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.11% | 0.00% | 88,420 | 88,420 | 100.00% | 3,120,342 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.11% | 0.01% | 85,652 | 85,652 | 100.00% | 3,022,659 | Jun 30, 2024 |
| TROLUCE CAPITAL ADVISORS LLC | 0.06% | 0.17% | 50,000 | 50,000 | 100.00% | 1,764,500 | Jun 30, 2024 |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 0.06% | 0.02% | 48,845 | 48,845 | 100.00% | 1,723,740 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.01% | 43,414 | 43,414 | 100.00% | 1,532,080 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 39,640 | 39,640 | 100.00% | 1,399,607 | Jun 30, 2024 |
| CINCTIVE CAPITAL MANAGEMENT LP | 0.04% | 0.06% | 34,529 | 34,529 | 100.00% | 1,218,528 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.03% | 0.00% | 27,821 | 27,821 | 100.00% | 981,803 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.03% | 0.00% | 26,028 | 26,028 | 100.00% | 918,529 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.03% | 0.01% | 25,000 | 25,000 | 100.00% | 882,250 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.03% | 0.01% | 23,600 | 23,600 | 100.00% | 832,844 | Jun 30, 2024 |
| VIRTUE CAPITAL MANAGEMENT, LLC | 0.03% | 0.17% | 22,227 | 22,227 | 100.00% | 974,654 | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.02% | 0.00% | 19,152 | 19,152 | 100.00% | 675,874 | Jun 30, 2024 |
| ABRDN PLC | 0.02% | 0.00% | 17,869 | 17,869 | 100.00% | 630,597 | Jun 30, 2024 |
| GILDER GAGNON HOWE & CO LLC | 0.02% | 0.01% | 17,546 | 17,546 | 100.00% | 619,198 | Jun 30, 2024 |
| GENESEE CAPITAL ADVISORS, LLC | 0.02% | 0.28% | 16,359 | 16,359 | 100.00% | 577,309 | Jun 30, 2024 |
| HANDELSBANKEN FONDER AB | 0.02% | 0.00% | 15,900 | 15,900 | 100.00% | 561,000 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.02% | 0.00% | 15,400 | 15,400 | 100.00% | 543,466 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT B.V. | 0.02% | 0.12% | 14,016 | 14,016 | 100.00% | 485,654 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.02% | 0.08% | 12,460 | 12,460 | 100.00% | 439,713 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.01% | 0.00% | 10,053 | 10,053 | 100.00% | 354,770 | Jun 30, 2024 |
| FORA CAPITAL, LLC | 0.01% | 0.04% | 8,222 | 8,222 | 100.00% | 290,154 | Jun 30, 2024 |
| COMPAGNIE LOMBARD ODIER SCMA | 0.01% | 0.00% | 7,000 | 7,000 | 100.00% | 247,030 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 0.01% | 0.00% | 6,000 | 6,000 | 100.00% | 211,740 | Jun 30, 2024 |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 0.01% | 0.00% | 5,740 | 5,740 | 100.00% | 203,000 | Jun 30, 2024 |
| MIRABELLA FINANCIAL SERVICES LLP | 0.01% | 0.01% | 5,698 | 5,698 | 100.00% | 201,082 | Jun 30, 2024 |
| FIRST HORIZON ADVISORS, INC. | 0.00% | 0.00% | 153 | 153 | 100.00% | 5,399 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 81 | 81 | 100.00% | 2,858 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | - | 0.00% | 32 | 32 | 100.00% | 1,133 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | - | - | 27 | 27 | 100.00% | 953 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | - | - | 5 | 5 | 100.00% | 208 | Jun 30, 2024 |
Dyne Therapeutics's largest new institutional shareholder by number of shares is HOLOCENE ADVISORS, LP, purchased 2.08M shares, valued at $73.27M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -435,256 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -100,656 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -99,822 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -42,817 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -29,138 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -27,382 | -100.00% | - | Jun 30, 2024 |
| SHAY CAPITAL LLC | - | - | - | -21,700 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -20,248 | -100.00% | - | Jun 30, 2024 |
| CONCURRENT INVESTMENT ADVISORS, LLC | - | - | - | -20,200 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -18,613 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -18,011 | -100.00% | - | Jun 30, 2024 |
| LPL FINANCIAL LLC | - | - | - | -15,114 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -14,000 | -100.00% | - | Jun 30, 2024 |
| REDMOND ASSET MANAGEMENT, LLC | - | - | - | -12,500 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -10,500 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -7,940 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,137 | -100.00% | - | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | - | - | - | -1,210 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -464 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -297 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -9 | -100.00% | - | Jun 30, 2024 |
Dyne Therapeutics's largest sold out institutional shareholder by shares sold is NANTAHALA CAPITAL MANAGEMENT, LLC, sold -0.44M shares, valued at -, as of undefined.
Dyne Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| HARTFORD HLS SERIES FUND II INC | 0.62% | 152,094 | - | - | Dec 31, 2023 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.32% | 662,251 | 662,251 | - | Feb 29, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.15% | 10,535 | - | - | Sep 30, 2022 |
| FRANKLIN STRATEGIC SERIES | 0.13% | 1,091,934 | - | - | Jan 31, 2024 |
| Vericimetry Funds | 0.10% | 9,130 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.10% | 495,007 | 495,007 | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.10% | 243,182 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 32,045 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.06% | 148,946 | -11,288 | -7.04% | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.06% | 1,088,284 | 1,088,284 | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust | 0.05% | 11,606 | 11,606 | - | Mar 31, 2024 |
| WASATCH FUNDS TRUST | 0.04% | 399,662 | -866,837 | -68.44% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.03% | 902,300 | 902,300 | - | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 103,627 | 25,917 | 33.35% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 8,677 | 2,086 | 31.65% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 926,313 | 150,000 | 19.32% | Feb 29, 2024 |
| IndexIQ ETF Trust | 0.01% | 28,236 | -1,980 | -6.55% | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,259 | 1,401 | 163.29% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,962,620 | 388,736 | 15.10% | Mar 31, 2024 |
| Humankind Benefit Corp | 0.01% | 135 | - | - | Dec 31, 2023 |
| VANGUARD EXPLORER FUND | 0.01% | 65,723 | - | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 33,738 | 33,738 | - | Aug 31, 2023 |
| ETFis Series Trust I | 0.00% | 6,943 | -1,029 | -12.91% | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.00% | 10,400 | - | - | Mar 28, 2024 |
| North Square Investments Trust | 0.00% | 38,620 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.00% | 28,736 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 36,984 | - | - | Mar 31, 2024 |
| FORUM FUNDS | 0.00% | 7,745 | 7,745 | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 125,259 | 11,623 | 10.23% | Jan 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 11,716 | 11,716 | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 534,494 | 158,013 | 41.97% | Feb 29, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 5,600 | 5,600 | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,896 | 1,291 | 28.03% | Mar 31, 2024 |
| Franklin Custodian Funds | 0.00% | 1,000,000 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 17,943 | 8,375 | 87.53% | Mar 31, 2024 |
| BNY MELLON FUNDS TRUST | 0.00% | 114,179 | - | - | Aug 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 41,510 | 11,096 | 36.48% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 5,273 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 14,212 | 71 | 0.50% | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 53,803 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 157,501 | 48,041 | 43.89% | Jan 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 37,053 | - | - | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 91,640 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 15,331 | -178 | -1.15% | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 66,205 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 8,308 | -684 | -7.61% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 559 | 559 | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 276,067 | -531 | -0.19% | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 18,959 | 1,497 | 8.57% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,834 | 784 | 38.24% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,463 | 914 | 166.48% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 43,322 | -45,282 | -51.11% | Jan 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 28,768 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 294,004 | 104,826 | 55.41% | Feb 29, 2024 |
| Managed Portfolio Series | 0.00% | 11,131 | - | - | Jan 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 14,635 | -4,430 | -23.24% | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 1,559 | - | - | Mar 28, 2024 |
| Global X Funds | 0.00% | 15,804 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 371,843 | 355,456 | 2169.13% | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 21,300 | 7,100 | 50.00% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 73,977 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 41,770 | 6,579 | 18.70% | Mar 28, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 276,180 | -175,500 | -38.85% | Jan 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 319,900 | 319,900 | - | Feb 29, 2024 |
| Trust for Advised Portfolios | 0.00% | 4,793 | - | - | Dec 31, 2023 |
| OHIO NATIONAL FUND INC | 0.00% | 4,564 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 55,941 | -19,792 | -26.13% | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 3,744 | 1,265 | 51.03% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 1,558 | 1,558 | - | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 2,487,250 | 469,936 | 23.30% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 164,060 | 46,426 | 39.47% | Mar 31, 2024 |
| Northern Lights Fund Trust IV | 0.00% | 41,123 | - | - | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 9,173 | 5,908 | 180.95% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 198,531 | 30,951 | 18.47% | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 9,040 | - | - | Feb 29, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 1,485 | - | - | Mar 31, 2024 |
| JPMorgan Trust I | 0.00% | 114,157 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 388 | - | - | Dec 31, 2023 |
| SPDR SERIES TRUST | 0.00% | 2,869,265 | 1,405,648 | 96.04% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 9,374 | 2,349 | 33.44% | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,900 | 300 | 18.75% | Mar 28, 2024 |
| VALIC Co I | 0.00% | 17,071 | 694 | 4.24% | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 6,451 | -16,229 | -71.56% | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,838 | - | - | Dec 31, 2023 |
| ALLSPRING MASTER TRUST | 0.00% | 3,310 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 20,464 | -6,949 | -25.35% | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 12,384 | 3,003 | 32.01% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 6,412 | 1,105 | 20.82% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 192 | - | - | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 4,155 | 737 | 21.56% | Feb 29, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 4,514 | 187 | 4.32% | Mar 31, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 8,069 | 8,069 | - | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 298,107 | - | - | Jan 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 342 | - | - | Feb 29, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 3,894 | 3,894 | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 179 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 72,876 | 12,800 | 21.31% | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 680 | -190 | -21.84% | Mar 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 5,824 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 70,265 | -59,817 | -45.98% | Jan 31, 2024 |
Dyne Therapeutics's largest mutual fund holder by % of total assets is "HARTFORD HLS SERIES FUND II INC", owning 152.09K shares, compromising 0.62% of its total assets.
Dyne Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 197 | 12.57% |
| 31 Mar, 24 | 175 | 28.68% |
| 31 Dec, 23 | 136 | 13.33% |
| 30 Sep, 23 | 120 | - |
| 30 Jun, 23 | 120 | -6.25% |
| 31 Mar, 23 | 128 | 11.30% |
| 31 Dec, 22 | 115 | 11.65% |
| 30 Sep, 22 | 103 | 17.05% |
| 30 Jun, 22 | 88 | -5.38% |
| 31 Mar, 22 | 93 | 1.09% |
| 31 Dec, 21 | 92 | 13.58% |
| 30 Sep, 21 | 81 | 8.00% |
| 30 Jun, 21 | 75 | 2.74% |
| 31 Mar, 21 | 73 | 5.80% |
| 31 Dec, 20 | 69 | 38.00% |
| 30 Sep, 20 | 50 | - |
As of 30 Jun 24, 197 institutions are holding Dyne Therapeutics's shares, representing an increase of 12.57% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 110,993,406 | 16.43% |
| 31 Mar, 24 | 95,333,552 | 36.34% |
| 31 Dec, 23 | 69,922,234 | 16.75% |
| 30 Sep, 23 | 59,888,841 | 1.18% |
| 30 Jun, 23 | 59,189,838 | 8.35% |
| 31 Mar, 23 | 54,627,841 | 9.41% |
| 31 Dec, 22 | 49,927,774 | 12.04% |
| 30 Sep, 22 | 44,561,545 | -4.55% |
| 30 Jun, 22 | 46,684,104 | -2.45% |
| 31 Mar, 22 | 47,857,383 | 0.13% |
| 31 Dec, 21 | 47,795,476 | 35.53% |
| 30 Sep, 21 | 35,266,489 | -1.50% |
| 30 Jun, 21 | 35,805,203 | 4.27% |
| 31 Mar, 21 | 34,339,637 | 17.19% |
| 31 Dec, 20 | 29,301,578 | 6.60% |
| 30 Sep, 20 | 27,487,960 | - |
Dyne Therapeutics (DYN) has 110.99M shares outstanding as of 30 Jun 24, up 16.43% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 136.95% | 0.99% |
| 31 Mar, 24 | 117.63% | 0.91% |
| 31 Dec, 23 | 113.89% | 1.19% |
| 30 Sep, 23 | 98.00% | 1.00% |
| 30 Jun, 23 | 98.92% | 1.05% |
| 31 Mar, 23 | 96.99% | 1.05% |
| 31 Dec, 22 | 96.06% | 1.30% |
| 30 Sep, 22 | 86.03% | 1.05% |
| 30 Jun, 22 | 90.33% | 1.05% |
| 31 Mar, 22 | 92.74% | 1.08% |
| 31 Dec, 21 | 92.73% | 1.96% |
| 30 Sep, 21 | 68.72% | 1.41% |
| 30 Jun, 21 | 69.91% | 1.45% |
| 31 Mar, 21 | 69.41% | 1.64% |
| 31 Dec, 20 | 65.03% | 1.74% |
| 30 Sep, 20 | 61.08% | - |
As of 30 Jun 24, Dyne Therapeutics is held by 136.95% institutional shareholders, representing a 0.99% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 126 | -1.56% |
| 31 Mar, 24 | 128 | 85.51% |
| 31 Dec, 23 | 69 | 16.95% |
| 30 Sep, 23 | 59 | -18.06% |
| 30 Jun, 23 | 72 | -1.37% |
| 31 Mar, 23 | 73 | 23.73% |
| 31 Dec, 22 | 59 | 1.72% |
| 30 Sep, 22 | 58 | 70.59% |
| 30 Jun, 22 | 34 | -5.56% |
| 31 Mar, 22 | 36 | -26.53% |
| 31 Dec, 21 | 49 | 25.64% |
| 30 Sep, 21 | 39 | -11.36% |
| 30 Jun, 21 | 44 | -13.73% |
| 31 Mar, 21 | 51 | 13.33% |
| 31 Dec, 20 | 45 | -10.00% |
| 30 Sep, 20 | 50 | - |
126 institutional shareholders have increased their position in DYN stock as of 30 Jun 24 compared to 128 in the previous quarter (a -1.56% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 46 | 58.62% |
| 31 Mar, 24 | 29 | -27.50% |
| 31 Dec, 23 | 40 | 25.00% |
| 30 Sep, 23 | 32 | 14.29% |
| 30 Jun, 23 | 28 | -9.68% |
| 31 Mar, 23 | 31 | -6.06% |
| 31 Dec, 22 | 33 | 17.86% |
| 30 Sep, 22 | 28 | -9.68% |
| 30 Jun, 22 | 31 | -3.13% |
| 31 Mar, 22 | 32 | 60.00% |
| 31 Dec, 21 | 20 | - |
| 30 Sep, 21 | 20 | 53.85% |
| 30 Jun, 21 | 13 | 18.18% |
| 31 Mar, 21 | 11 | 22.22% |
| 31 Dec, 20 | 9 | - |
| 30 Sep, 20 | - | - |
46 institutional shareholders have reduced their position in DYN stock as of 30 Jun 24 compared to 29 in the previous quarter (a 58.62% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 197 | 12.57% | 110,993,406 | 16.43% | 136.95% | 0.99% | 126 | -1.56% | 46 | 58.62% |
| 31 Mar, 24 | 175 | 28.68% | 95,333,552 | 36.34% | 117.63% | 0.91% | 128 | 85.51% | 29 | -27.50% |
| 31 Dec, 23 | 136 | 13.33% | 69,922,234 | 16.75% | 113.89% | 1.19% | 69 | 16.95% | 40 | 25.00% |
| 30 Sep, 23 | 120 | - | 59,888,841 | 1.18% | 98.00% | 1.00% | 59 | -18.06% | 32 | 14.29% |
| 30 Jun, 23 | 120 | -6.25% | 59,189,838 | 8.35% | 98.92% | 1.05% | 72 | -1.37% | 28 | -9.68% |
| 31 Mar, 23 | 128 | 11.30% | 54,627,841 | 9.41% | 96.99% | 1.05% | 73 | 23.73% | 31 | -6.06% |
| 31 Dec, 22 | 115 | 11.65% | 49,927,774 | 12.04% | 96.06% | 1.30% | 59 | 1.72% | 33 | 17.86% |
| 30 Sep, 22 | 103 | 17.05% | 44,561,545 | -4.55% | 86.03% | 1.05% | 58 | 70.59% | 28 | -9.68% |
| 30 Jun, 22 | 88 | -5.38% | 46,684,104 | -2.45% | 90.33% | 1.05% | 34 | -5.56% | 31 | -3.13% |
| 31 Mar, 22 | 93 | 1.09% | 47,857,383 | 0.13% | 92.74% | 1.08% | 36 | -26.53% | 32 | 60.00% |
| 31 Dec, 21 | 92 | 13.58% | 47,795,476 | 35.53% | 92.73% | 1.96% | 49 | 25.64% | 20 | - |
| 30 Sep, 21 | 81 | 8.00% | 35,266,489 | -1.50% | 68.72% | 1.41% | 39 | -11.36% | 20 | 53.85% |
| 30 Jun, 21 | 75 | 2.74% | 35,805,203 | 4.27% | 69.91% | 1.45% | 44 | -13.73% | 13 | 18.18% |
| 31 Mar, 21 | 73 | 5.80% | 34,339,637 | 17.19% | 69.41% | 1.64% | 51 | 13.33% | 11 | 22.22% |
| 31 Dec, 20 | 69 | 38.00% | 29,301,578 | 6.60% | 65.03% | 1.74% | 45 | -10.00% | 9 | - |
| 30 Sep, 20 | 50 | - | 27,487,960 | - | 61.08% | - | 50 | - | - | - |
Dyne Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Dyne Therapeutics's stock was made by Kersten Dirk on Aug 16 2024, selling 100,650 shares at $43.67 per share (valued at $4.40M).
Dyne Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 20 | - |
| Q2 2024 | 12 | 32 | 37.50% |
| Q1 2024 | 27 | 149 | 18.12% |
| Q4 2023 | 12 | 11 | 109.09% |
| Q3 2023 | 1 | 11 | 9.09% |
| Q2 2023 | 10 | 18 | 55.56% |
| Q1 2023 | 1 | 11 | 9.09% |
| Q4 2022 | 16 | 11 | 145.45% |
| Q3 2022 | 19 | 9 | 211.11% |
| Q2 2022 | 11 | 6 | 183.33% |
| Q1 2022 | 1 | 7 | 14.29% |
| Q4 2021 | 12 | 2 | 600.00% |
| Q3 2021 | 1 | 10 | 10.00% |
| Q2 2021 | 7 | - | - |
| Q1 2021 | 2 | - | - |
| Q3 2020 | 56 | 48 | 116.67% |
| Q2 2018 | - | 28 | - |
| Q1 2018 | 6 | 12 | 50.00% |
| Q4 2017 | 1 | 2 | 50.00% |
| Q2 2017 | 4 | - | - |
0 total buy trades, and 20 total sell trades (buy/sell ratio of 0.00%) were made by Dyne Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 20 | - |
| Q2 2024 | - | 26 | - |
| Q1 2024 | 2 | 122 | 1.64% |
| Q4 2023 | - | 11 | - |
| Q3 2023 | - | 11 | - |
| Q2 2023 | - | 12 | - |
| Q1 2023 | - | 9 | - |
| Q4 2022 | 2 | 7 | 28.57% |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 7 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 9 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q3 2020 | 15 | - | - |
| Q2 2018 | - | - | - |
| Q1 2018 | - | 1 | - |
| Q4 2017 | - | - | - |
| Q2 2017 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 20 open market sell trades of Dyne Therapeutics's stocks.
Dyne Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| DICE | DICE Therapeutics, Inc. |
| PLRX | Pliant Therapeutics, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| ERAS | Erasca, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| CYTK | Cytokinetics, Incorporated |
| KRTX | Karuna Therapeutics, Inc. |
DYN Ownership FAQ
Who Owns Dyne Therapeutics?
Dyne Therapeutics is owned by institutional shareholders (136.95%), insiders (0.39%), and public (-37.35%). The largest institutional shareholder of Dyne Therapeutics is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC (9.90% of total shares) and the top mutual fund owner is HARTFORD HLS SERIES FUND II INC (0.62% of total shares).
Who are the major institutional shareholders of Dyne Therapeutics?
Dyne Therapeutics's major institutional shareholders are ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, FCPM III SERVICES B.V., BLACKROCK INC., RTW INVESTMENTS, LP, and RA CAPITAL MANAGEMENT, L.P.. The top five shareholders own together 44.04% of the company's share outstanding.
How many Dyne Therapeutics shareholders are there?
As of Jun 2024, there are 197 institutional shareholders of Dyne Therapeutics.
What percentage of Dyne Therapeutics is owned by ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC?
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC owns 8.02M shares of Dyne Therapeutics, representing 9.90% of the company's total shares outstanding, valued at $283.03M (as of Jun 2024).
What percentage of Dyne Therapeutics is owned by FCPM III SERVICES B.V?
As of Jun 2024, FCPM III SERVICES B.V holds 7.85M shares of Dyne Therapeutics (DYN), compromising 9.68% of the company, valued at $276.86M.
What percentage of Dyne Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Dyne Therapeutics. The company owns 7.39M of the company's shares outstanding (worth $260.69M).